H. Fisher

发表

Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)

A. Bagai, S. Mehta, A. Yan, 2022, Heart and Vessels.

Use of drotrecogin alfa (activated) in a severe acute respiratory syndrome patient with severe sepsis.

H. Fisher, D. McRitchie, Warda Farooq, 2008, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients

M. Effron, H. Fisher, D. Angiolillo, 2014, Thrombosis and Haemostasis.

Effect on Platelet Reactivity From a Prasugrel Loading Dose After a Clopidogrel Loading Dose Compared With a Prasugrel Loading Dose Alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): A Randomized Controlled Trial

M. Effron, H. Fisher, D. Angiolillo, 2013, Circulation. Cardiovascular interventions.

Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy.

S. Mehta, A. Yan, M. Tan, 2016, American heart journal.

Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy.

P. Dehghani, A. Bagai, S. Mehta, 2017, International journal of cardiology.

Baseline characteristics, adenosine diphosphate receptor inhibitor treatment patterns, and in-hospital outcomes of myocardial infarction patients undergoing percutaneous coronary intervention in the prospective Canadian Observational AntiPlatelet sTudy (COAPT).

P. Dehghani, S. Mehta, S. Goodman, 2016, American heart journal.

A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care

A. Day, D. Heyland, R. Fowler, 2007, Critical care.

A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care

A. Day, D. Heyland, R. Fowler, 2007, Critical care.

Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study

A. Bagai, S. Mehta, A. Yan, 2016, European heart journal. Quality of care & clinical outcomes.

Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)

A. Bagai, S. Mehta, A. Yan, 2022, Heart and Vessels.

A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care

A. Day, D. Heyland, R. Fowler, 2008, Critical Care.

Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT)

A. Bagai, S. Mehta, W. Cantor, 2018, Clinical cardiology.

Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort

H. Fisher, R. Hall, J. Russell, 2009, Critical care.

A prospective, observational registry of patients with severe sepsis: The Canadian Sepsis Treatment and Response Registry*

S. Keenan, D. Heyland, R. Fowler, 2009, Critical care medicine.

THE CANADIAN SEPSIS TREATMENT AND RESPONSE (STAR) REGISTRY: ILLNESS SEVERITY AND PROCESS OF CARE FOR PATIENTS WITH SEVERE SEPSIS: 533

S. Keenan, D. Heyland, F. Priestap, 2004 .

A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care

A. Day, D. Heyland, R. Fowler, 2008, Critical Care.

MARITAL STATUS, LIVING ARRANGEMENT, AND OUTCOMES FOLLOWING MYOCARDIAL INFARCTION: OBSERVATIONS FROM THE CANADIAN OBSERVATIONAL ANTIPLATELET STUDY (COAPT)

A. Bagai, S. Mehta, W. Cantor, 2016 .